REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action - Contact SueWallSt
SueWallSt, powered by Levi & Korsinsky LLP, issued a solicitation reminding investors of the September 14, 2026 lead plaintiff deadline in a class action lawsuit against Regeneron Pharmaceuticals. The complaint alleges Regeneron made misleading statements regarding a protocol amendment in the Phase III Fianlimab-Libtayo study, which raised concerns about statistical significance and progression-free survival.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.